Australia markets closed

NovaBay Pharmaceuticals, Inc. (NBY)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
0.0900+0.0004 (+0.45%)
At close: 04:00PM EDT
0.0900 0.00 (0.00%)
After hours: 07:03PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 3.25M
Enterprise value 4.81M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.03
Price/book (mrq)2.38
Enterprise value/revenue 0.33
Enterprise value/EBITDA -1.00

Trading information

Stock price history

Beta (5Y monthly) 2.01
52-week change 3-90.72%
S&P500 52-week change 321.33%
52-week high 31.2800
52-week low 30.0700
50-day moving average 30.1154
200-day moving average 30.3222

Share statistics

Avg vol (3-month) 32.36M
Avg vol (10-day) 31.82M
Shares outstanding 536.06M
Implied shares outstanding 636.06M
Float 829.96M
% held by insiders 10.03%
% held by institutions 13.30%
Shares short (15 Apr 2024) 4208.11k
Short ratio (15 Apr 2024) 40.09
Short % of float (15 Apr 2024) 40.58%
Short % of shares outstanding (15 Apr 2024) 40.58%
Shares short (prior month 15 Mar 2024) 4116.07k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:35
Last split date 316 Nov 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -65.46%
Operating margin (ttm)-21.41%

Management effectiveness

Return on assets (ttm)-24.59%
Return on equity (ttm)-139.02%

Income statement

Revenue (ttm)14.73M
Revenue per share (ttm)3.49
Quarterly revenue growth (yoy)2.30%
Gross profit (ttm)N/A
EBITDA -4.8M
Net income avi to common (ttm)-16.7M
Diluted EPS (ttm)-3.9600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.13M
Total cash per share (mrq)0.1
Total debt (mrq)2.74M
Total debt/equity (mrq)82.68%
Current ratio (mrq)1.67
Book value per share (mrq)0.12

Cash flow statement

Operating cash flow (ttm)-4.13M
Levered free cash flow (ttm)-173.88k